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Authors debate about cholesteatomas, from the first
time this word was employed, by Muller, in 1838, until
the recent updates. They dissert about its definition,
etiology and pathology and present basic concepts about
its biology. They also make a wide review about
pediatric cholesteathoma, its epidemiology and biology,
and compare it with adult cholesteatoma. Finally, they
describe some articles about ossicle chain erosion and
its correlation with cholesteatoma perimatrix, collagen
and collagenase.
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The word
The word “cholesteatoma” was used for the first time
by the German anatomist Johannes Mueller, in 18381. The
roots of this word mean cole - cholesterol; esteado - fat; oma
- tumor, that is, a tumor in which we have fatty tissue and
cholesterol crystals. Etymologically, this term is completely
incorrect, and it is considered the second wrong term in
otology (the first one is acoustic neuroma, given that it is in
fact a vestibular nerve Schwannoma)2. The use of this
denomination is inappropriate because cholesteatoma is
originated from the keratinized squamous epithelium of the
tympanic membrane and/or external auditory canal, without
presence of cholesterol crystals or fat in its structure, in
addition to the fact that the tumor nature is completely
discussable.
Other suggested denominations were pearl tumor,
by Cruveilhier, in 1829; margaritoma, by Craigie, in 1891,
epidermal cholesteatoma by Cushing, in 1922,
epidermoid by Critchley and Ferguson, in 1928 and
keratoma, by Shuknecht, in 1974; all these terms even
though they are more appropriate and descriptive, are
not employed and the term cholesteatoma is widely used
by otologists.
Definition
Cholesteatomas were defined by Friedmann3, in 1959,
as cystic structures recovered with stratified squamous cell
epithelium, laying over a fibrous stroma of variable thickness,
which can contain some elements from the original mucous
lining.
Schuknecht4, in 1974, defined them as accumulation
of exfoliated keratin inside the middle ear or any
pneumatized area of the temporal bone, originated from
the keratinized squamous epithelium. Informally, the author
stated that the cholesteatoma could be characterized as “skin
on the wrong side”.
Epidemiology
Annual incidence of cholesteatoma ranges around 3
in 100,000 in children and 9 in 100,00 in adults, and it is
more predominant in male 5,6.
Epidemiological data show high prevalence of
cholesteatoma among Caucasian people, followed by
African descendents, and it is rarely detected in Asian
population. According to Ratnesar7, this prevalence is
very low in Inuit Eskimos, suggesting that their
anatomical morphological characteristics may facilitate
the aeration of the middle ear and prevent sequels of
chronic otitis.
In the Ambulatory of Chronic Otitis Media, Hospital
de Clínicas de Porto Alegre (AOMC-HCPA), out of 450
patients followed up since August 2000, 30% had
cholesteatomatous chronic otitis media (CCOM), presenting
bilaterally in 12% of the total sample. Out of the patients
with CCOM, 45% were aged up to 18 years, considered to
be pediatric patients. As to gender, we found 70% of male
cases 8.
Classification
Cholesteatomas are normally classified as congenital
and acquired and they are subdivided into primary and
secondary.
Congenital cholesteatomas are epithelial remains
found in ears with intact tympanic membrane and without
previous history of infections 9. According to Valvassori10,
they are found in four regions of the temporal bone:
tympanic-mastoid, petrous apex, cerebello-pontine angle
and jugular foramen. There is a fifth explanation,
described by Sobol11, that reported the existence of small
epithelial pearls between the tympanic membrane
layers.
Acquired primary cholesteatomas are resultant from
tympanic retractions that would accumulate the desquamated
epithelium and would lose their self-cleaning power.
Secondary cholesteatomas would be formed from the
migration of the epithelium through a marginal perforation
in the tympanic membrane (Costa et al., 1999).
Meyerhoff and Truelson6 tried to classify
cholesteatomas according to the pathophysiology, location,
ossicle defects and presence of complications, dividing them
into congenital and acquired, and the latter into primary,
secondary and tertiary.
Tos6 proposed another classification based on site of
origin of cholesteatoma, which considers it as an important
factor for the surgical procedure and the prognosis. This
taxonomy presents three categories:
1. Attic Cholesteatoma - retraction of the flaccid pars or
Shrapnell membrane, extending to the attic, going through
the aditus and eventually reaching the antrum, mastoid
or tympanic cavity.
2. Tympanic sinus Cholesteatoma - posterior-superior
retraction or perforation of pars tense, extending to the
tympanic sinus and posterior portion of the tympanic
membrane.
3. Pars tense Cholesteatoma - retraction and total adhesion
of the pars tense of tympanic membrane involving the
tympanic orifice of the auditory tube.
Saleh and Mills13 proposed another classification,
according to the site affected by the cholesteatoma,
characterized as follows:
S1 - if the cholesteatoma is restricted to the site where it
had started;
S2 - when the disease extends to other site;
S3 - if it affects three sites;
S4 - if it is installed in four sites;
538
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 71 (4) PART 1 JULY/AUGUST 2005
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
S5 - to cases in which the primary site is affected plus four
or more are also involved.
The same authors distinguished seven sites used to
this classification: attic and antrum, middle ear, mastoid,
auditory tube, labyrinth and middle fossa. The staging is a
practical solution to describe disease extension and it is
clinically relevant, which may be applied to all lesions except
to the petrous apex, which cannot be diagnosed by otoscopy.
Saleh and Mills13 also presented a classification of the
ossicle chain condition, based on the descriptions by Wullstein
(1956) and Austin (1969), through the following score:
0 - if the ossicle chain is intact;
1 - if incus is eroded and without chain discontinuity;
2 - if incus and stapes suprastructures are eroded;
3 - if the malleus head and incus are absent and stapes
superstructure if eroded.
As to preoperative complications, Saleh and Mills13
classified cholesteatomatous chronic otitis media as:
C0 - when there are complications;
C1 - to the occurrence of complications;
C2 - to the existence of two or more.
As to complications, the authors consider lateral
semicircular canal fistula, facial palsy, total sensorineural
auditory loss, sinus thrombosis and intracranial invasion.
Deep understanding about the pathogenesis of the
middle ear cholesteatoma is particularly important, given
that the destructive nature is responsible for many of the
referred complications. The trend to bone erosion of
cholesteatomas and the lack of non-surgical treatment justify
the importance of the investigation of basic mechanisms
related to development of cholesteatomatous chronic otitis
media.
Etiopathogenesis
Ferlito14 described that three disposing conditions
would be necessary for the development of cholesteatoma:
a) the junction of two different epithelia in the auditory
opening; b) the chronic destruction of the middle ear
submucous layer by infectious and inflammatory processes;
c) the scaring process or the proliferation phase.
However, the etiopathogenesis of cholesteatomas is
still very much discussed and basically there are six main
hypotheses (Chart 1), which have generated controversy
for over 100 years.
There are a number of studies about the pathogenesis
of cholesteatomas, but there is still a lot to be clarified 15. As
observed in AOMC-HCPA and in many different studies of
this group 8,16-22 these hypotheses would not individually
explain the pathogeneses of all cholesteatomas.
The existence of congenital cholesteatomas and the
onset of cholesteatoma by invagination and implantation is
unequivocal, but these situations would not be responsible
for all cases of CCOM. We believe that the pathogenesis of
cholesteatoma in fact would involve many different
aggregated hypotheses (Chart 1), and there may be an
overlapping of two or more of them in each patient.
As a consequence of this fact, it seems that the
hypothesis of the continuum, advocated by Michael
Paparella23, in 1970, is close to a multifactorial and more
comprehensive conception of pathogenesis. According to
it, otitis media would exist throughout a continuous series of
epithelial and subepithelial events, in which after the initial
insult, the serous or purulent otitis would become serum-
mucoid, mucoid or finally, if there were no spontaneous or
therapeutic regression of the condition, there would be
chronic transformation. We can say, based on this hypothesis,
that the cholesteatoma is a complex of one single middle
ear pathology, chronic otitis media, and not an isolated event.
Structure
Macroscopically, cholesteatoma is a round or oval cystic
lesion with variable configuration and size. Ferlito et al.14
characterized cholesteatoma as an epidermoid cyst of
independent and progressive growth with destruction of
adjacent tissues, especially the bone tissue, with tendency
to recurrence.
The advent of transmission electron microscopy
allowed many advances in the knowledge about cell
structure. Using this instrument, Lim and Saunders24 in 1972
presented a detailed histological description of
cholesteatomas. They described that the cholesteatoma has
a keratinized stratified squamous epithelium with four layers
identical to normal epidermis (basal, spinosum, granulosum
and corneal), Langerhans cells (in larger amounts than in
normal epidermis) and keratin-hyaline granules. They named
this epithelium as cholesteatoma matrix. They also observed
the presence of connective tissue, containing collagen fibers,
fibrocytes and inflammatory cells, which was named
perimatrix, which is in most of the cases in contact with
squamous or ciliated cylindrical cells, remains from the
original middle ear mucosa. In some cases, despite the fact
Chart 1. Main hypotheses for the etiopathogenesis of
cholesteatomas.
Hypothesis Author Years
Congenital Cholesteatomas Korner and Virchow 1863
Metaplasia Wendt 1873
Migration Habermann 1889
Bezold 1889
Invagination Bezold 1908
Hyperplasia Manasse 1917
Implantation Schöer 1958
539
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 71 (4) PART 1 JULY/AUGUST 2005
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
that the perimatrix is absent at optical microscopy, it was
present when studied under transmission electron
microscopy, proving to be extremely thin, with collagen
fibers that were practically absent and containing sodium
carbonate crystals. In the study conducted by Paludetti et
al.25, the perimatrix consisted of granulation tissue or inflamed
subepithelial connective tissue.
According to Milewski et al.26, the growth of
cholesteatoma could require angiogenesis in the perimatrix
connective tissue, and cells and substances of the scaring
cascade would have an important role in the development
and growth of cholesteatoma. These processes would involve
the fibroblastic growth factor b (b-FGF), which according to
some authors, could stimulate collagenase. They also
suggested that persistence of inflammation would cause a
permanent process of scaring in the perimatrix, proliferation
of fibroblasts (granulation tissue) and epithelium (matrix).
Ferlito et al.14 described the perimatrix as the most
peripheral portion of the cholesteatoma, comprising
granulation tissue or inflammatory subepithelial connective
tissue, with lymphocytes, hystiocytes and neutrophils.
Sprekelsen et al.27 stated that the matrix and perimatrix, in
normal or pathological tissues, are formed by type IV
collagen, tenascin, fibronectin, b-FGF and metalloproteinase
(MMP). According to Jacob et al.28, the increment in
proliferation of the cholesteatoma matrix would be the result
of the inflammation process, suggesting that the perimatrix
would be the main factor of cholesteatoma development.
In summary, we can define the perimatrix as an
inflammatory network that involves the cholesteatoma.
Figure 1 presents a histological section of a cholesteatoma,
in which we can see the structural components: perimatrix,
matrix and cystic content.
Pereira et al.29 studying 31 cholesteatomas - 20 adults
and 11 children, found nine specimens without perimatrix,
visible under optical microscopy, two in adults and seven in
pediatric cases. These findings corroborate those reported
by Lim and Saunders24, which confirmed that many
perimatrixes can only be seen under electron microscopy.
These authors suggest that a possible cause of this reduction
in collagen fibers could be the result of a differential action
of collagenase.
Hamsei et al.30 analyzed 21 cholesteatomas through
polymerase chain reaction (PCR), immunohistochemistry
and histology, with the objective of investigating stimulation
factors and differentiation of osteoclasts into cholesteatoma,
using skin from the external acoustic canal as control. The
immunohistochemical analysis demonstrated an increase
in osteoclast and macrophage precursor cells in
cholesteatomas. The perimatrix analysis showed that in
these regions of the cholesteatoma, there are all factors
necessary for osteoclastogenesis and for stimulation of bone
reabsorption.
Biology of Cholesteatoma
The study of cells under optic and electron microscopy
may give us the mistaken impression that they are static
structures. However, to the contrary, many processes and
movements are constantly happening inside the cells,
occurring in some tissues quicker than in others. It is easy to
understand that as cells are getting differentiated, and parallel
they acquire some structural and physiological particularities.
Epithelia are tissues with limited life, with constant
renewal, resulting from continuous mitotic activity. The speed
of cell replacement is variable, and it may range from 2 to
50 days, depending on the tissue to be considered 31.
The connective tissue, in turn, comprising cholesteatoma
perimatrix, presents a growth process that is more complex
because it is formed by different types of cells - fibroblasts,
macrophages, mast cells, plasmocytes, leukocytes - separated
by abundant intercellular material. Richness of this material is
one of its most important characteristics. It is a part with defined
microscopic structure - connective fibers - and by another non-
structured portion - a substance that is fundamentally amorphous
31. Owing to this complexity, one could expect that the renewal
process of this tissue would be quite complex.
Cholesteatomatous chronic otitis media could be the
result of an uncontrolled cell proliferation; more simply, in
this pathology there is growth of keratinized squamous
epithelium cyst, the cholesteatoma14. It could be considered
as a disorder of the control of cell growth, comprising a
series of complex and dynamic events involving cell and
extracellular components with affections to their biological
behavior, such as keratinocyte deregulation 32, which present
a hyperproliferative growth and cell differentiation affections.
However, it is not known for sure whether this lack of control
is caused by defect to the genes that control the proliferation,
by cytokines released by inflammatory cells or by
mechanisms still unknown 12. Thus, determining the existence
Figure 1. Digitalized image of the lamina, cross section of a
cholesteatoma, stained with Hematoxylin-Eosin. We can see three
forming parts: A - perimatrix, B - matrix, C - cystic content.
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of defects in its biology, biochemistry and genetics is essential
to learn about the pathogenesis.
As previously described, the capacity to invade,
migrate, modify the differentiation, proliferation and
recurrence of cholesteatomas is quite similar to neoplasms,
but there is reluctance between researchers about accepting
the inclusion of cholesteatoma in this category 33,34.
For cholesteatoma to be considered a neoplastic lesion
it is necessary to have evidence of genetic instability; it may
be manifested through DNA affection or specific chromosomic
abnormalities. In 1995, Shinoda and Huang35 detected the
protein p53 in cholesteatomas, suggesting that they could be
tumors. However, Desloge et al.33 demonstrated that there
were no DNA affections, ruling out this hypothesis.
Given that the reported studies have not detected
any genetic instability in these lesions, we should investigate
another possible reason for the development of CCOM, being
necessary to ask about the origin of keratinized squamous
epithelium in cholesteatomas. To study this issue, many
investigations using immunohistochemical analysis have been
performed to compare the location of differentiation markers
in cholesteatomas and on the skin of the external auditory
canal. Owing to the properties of cytokeratins, they have
been considered by many investigators 36,37,32 as the best
instruments to this end.
Cytokeratins are proteins that form one of the two
categories of intermediate filaments, located on the cytoplasm
of epithelial cells; they have 20 subclasses, and their expression
is dependent on the type of epithelium and stage of
differentiation38. Pereira39, Albino et al.40 and Kim and Chung41
reported that matrix of cholesteatomas expresses cytokeratin
16 (CK16) on suprabasal layers, being that the expression of
this protein filament is characterized by hyperproliferative
epithelium. Lepercque et al.42 described that CK16 does not
show on the normal epithelium unless it is in areas under
pressure and friction, or on the recover epithelium of hair
follicles. According to Broekaert et al.43, CK16 is expressed in
specific regions, such as tympanic ring and medial and inferior
regions of the external acoustic canal. Pereira et al.29 stated
that the presence of CK16 in the matrix of the cholesteatoma
could indicate a hyperproliferative behavior, similar to
hyperproliferative epidermal disease. According to Albino et
al.40, cholesteatoma is formed as a result of the attempt to
repair the lesion, which could explain the presence of CK16,
characterizing this epithelium as immature with predominance
of cell proliferation. Kujipers et al.37 analyzed the pattern of
cytokeratins and suggested that the cholesteatoma matrix is
not a result of a metaplastic change. In the study, they found
an epithelium similar to that of the tympanic membrane and
to the skin of the external auditory canal, but in different
stages of proliferation, depending on the level of inflammation
present.
A characteristic signal of cholesteatoma is the infiltration
in the perimatrix of immune system cells. Piltcher44, in his
thesis about cytokines in chronic otitis media with effusion,
stated that in addition to the known risk factors, such as auditory
tube dysfunction and infections, many research studies about
otitis media have been directed to the study of different
components of the inflammatory response. The essential issue
is whether the inflammation should be considered only a
process of defense or whether it has a role in perpetuation of
cholesteatomatous chronic otitis media. Milewski45 suggested
that inflammatory cytokines, fibroblasts and macrophages
would be responsible for the origin, growth and bone
destruction of cholesteatoma. Many cytokines and growth
factors could be involved in the proliferation mechanism and
development of cholesteatoma epithelium 46,47. Tomita48 stated
that there are many hypotheses that growth factors and
cytokines, present in cholesteatomas, induce the activation
of genes, such as c-myc, causing the deregulation of cell
proliferation. Sudhoff et al. 49 investigated the distribution and
expression of tumor growth factor (TGF-alpha), epithelial
growth factor (EGF-R) and oncogene c-myc in normal epithelial
cells of middle ear and in cholesteatomas. These factors were
found in the cholesteatoma matrix, but not in normal cells. In
addition to autocrine regulation of epithelium, owing to
production of epithelial growth factor (EGF), cholesteatoma
hyperproliferation could depend on the interaction of the
subepithelial tissue and the inflammatory changes that occurred
in this pathology. Sudhoff et al.50 investigated the expression
and location of growth factors of angiogenesis in 22
cholesteatomas in comparison to normal epidermis of external
auditory canal (8) and to mucosa of normal middle ear (5), to
identify some growth factors involved in the pathogenesis of
cholesteatomas. These researchers found 5.3±1.2 vessels/mm2
on the normal skin and mucosa, whereas in the group with
cholesteatoma there was 21.1±11.7 vessels/mm2, and the mean
ranged according to degree of inflammation of perimatrix:
9.0±3.5 vessels/mm2 in grade I, 19.2±3.6 vessels/mm2 in grade
II and 31.7±9.4 vessels/mm2 in grade III. They also reported
a reduction in collagen type IV and laminin on the basal
membrane of the cholesteatoma, comparing to the controls.
A common characteristic in the pathogenesis of
many types of cholesteatoma is the presence of bacteria,
consequently, a large amount of cytokines released by
inflammatory cells resulting from the immune response.
The presence of bacteria to promote a critical link
between cholesteatoma and the host, preventing the
neoformed epithelium to conclude its process of
differentiation, which would promote a quiescent status,
minimally proliferative, without migration or invasion in
this step 51. The interactions between inflammatory cells
and epithelium of the cholesteatoma could be responsible
for the induction of aberrant biological characteristics of
the pathology.
Chole and Faddis51 studied, under electron transmission
microscopy, 24 human cholesteatomas and 22 cholesteatomas
in Mongolian squirrels. In the human sample, 16 presented
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histological findings consistent with biofilm bacteria, whereas
the material from the animal study showed 21 evidences of
bacteria. These findings could be related with the activity of
cholesteatoma, especially in persistent or recurrent infections
and with resistance of topical or systemic antimicrobials. The
authors suggested that the cholesteatoma matrix is an ideal
medium for the development of a mixed microbiological
biofilm. The authors stated that even though the bacteria in
the biofilm are resistant to antibiotics by different mechanisms
used by plankton bacterial, the exact mechanism of resistance
to bacteria colony in biofilm is still unknown.
Studies published so far presented many data about
the biology of cholesteatomas, but many questions still remain.
As previously referred, cholesteatomas present neoplastic
characteristics (invasion, migration, change in differentiation),
but to present, no indication of genetic instability has been
detected in the structure, a fact that rules out the possibility
of considering it a neoplasm. Another property that seems to
be constant in cholesteatomas is its hyperproliferative activity,
which might be a possible explanation to its aggressive
characteristics and uncontrolled growth. In addition, stimuli of
immune response, represented by cytokines related to
perimatrix inflammatory cells, represent a strong candidate
to the role of key player in this intricate plot of mechanisms.
All these hypotheses make us consider the complexity
involved in the biology of cholesteatomas and consequently
the multitude of events related with its pathogenesis.
Power of Bone Erosion
Cholesteatomas have great power of bone erosion 52,53.
They normally reach the ossicle chain and less frequently the
head bones, including the most rigid bone of the human body,
the labyrinth, which demonstrates its strong destructive action
over the bone tissue. Partial or total destruction of ossicle
chain is observed in about 80% of the patients with
cholesteatoma, whereas in non-cholesteatomatous chronic OM
there is erosion of ossicle chain in approximately 20% of the
cases 54,55. The mechanisms that lead to this increase in bone
degradation and invasion are currently being investigated 16.
According to Fisch56, complications caused by
cholesteatomas may be divided into two groups: intracranial
ones - meningitis, abscesses and venous sinus thrombosis,
and temporal bone ones - mastoiditis, labyrinthic fistula, facial
nerve palsy, labyrinthitis and ossicle destruction.
Sadé and Berco57 performed a histological exam in
80 ossicles obtained in surgery and 41 of them were from
patients with NCCOM and 39 from CCOM. Bone erosion
was found in 42.5% of the ossicles of patients without
cholesteatoma and in 84% of the patients with
cholesteatoma, and the difference was statistically
significant (P<0.001). In the study by Prescott58, 81 children
with CCOM were followed up; out of a total of 96
cholesteatomas (15 bilateral), there were only 19 integral
ossicle chains, 23 presented erosion of malleus and intact
suprastructure, 51 had erosion of malleus and loss of
suprastructure, and three were not described.
Sadé and Fuchs59 compared the findings of ossicle
erosion in adults (age t 14 years) to those found in children
(age d 13 years). The percentage of destruction of stapes
and malleus were similar in both groups; incus presented
significantly greater destruction in adults. Facial nerve palsy
and labyrinthic fistula were equally more destroyed in adults.
Dornelles et al.16 performed a study of the description of
middle ear findings in the transoperative period of 55 patients
with chronic otitis media, followed in the AOMC-HCPA. Out
of these patients, 49% had diagnosis of CCOM. In the sample,
there were 66% of cases with involvement of ossicle chain: in
cases of CCOM the rate was 96% whereas in NCCOM it
dropped to 37%. The presence of cholesteatoma was
associated with existence of two or more affected ossicles, as
well as higher prevalence of absence or erosion of ossicles.
These findings indicate that most patients with COM, submitted
to surgical intervention, have ossicle chain involvement and
that frequency and extension of impairment were much more
related with presence of cholesteatoma. In our group, we
categorized ages as: children up to 18 years and adults as of
19 years. When we analyzed the ossicle chain, observed in
the transoperative analysis of patients with CCOM, we found
100% of impairment in children and 92% in adults. When we
compared the ossicles separately, we reached 30% of affections
in the malleus, 30% in the stapes and 90% in the incus, without
statistically significant difference between adults and children.
Upon repeating the analysis following the same age
classification used by Sadé and Fuchs59, the results were
different from the ones reached by the authors, because we
did not find statistically significant differences when comparing
ossicles in children and adults 16.
According to Swartz60, ossicle destruction is more
common among complications of cholesteatomas and the
type of destruction depends on origin and mode of
expansion. According to the data, the ossicle chain is intact
in only 26% of the attic cholesteatomas, and the long process
of incus is the most affected region, followed by incus body
and malleus head. In turn, pars tense cholesteatomas have
power of erosion of 90%.
Bone absorption is stimulated by a variety of factors,
including inflammation, local pressure, specific cytokeratins
and keratin 6. The enzymatic concept in which enzymes of
epithelial origin are considered responsible for bone destruction
was defined by Abramson61-64, which demonstrated the
presence of collagenase and hydrolase in cholesteatoma, a
hypothesis that was later confirmed by Thompsen65. Ferlito
et al.14 suggested that the destructive property of
cholesteatomas - the bone erosion is caused by the production
of collagenase by the components of squamous and fibrous
epithelial tissues. It is not properly demonstrated yet whether
mineralized bone can be absorbed by collagenase. Other
agents were incorporated, such as tumor necrosis factor (TNF),
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interleukins (IL-1a) and prostaglandins (PGE
2
)66-68, to the
hypothesis of bone absorption by biochemical action,
exclusively played by collagenolytic enzymes.
Peek et al.69 studied the concentration of
lipopolysaccharides, components of the membrane of
gram-negative bacteria 70 in cholesteatomas and compared
to the level found in samples of patients with NCCOM.
They found higher concentrations in patients with
cholesteatoma and suggested that these results would be
related with high levels of bone reabsorption.
Pediatric Cholesteatoma
There are some references supporting that
cholesteatomas are more aggressive and would have less
favorable prognosis in children than in adults 71-75. Smythe et
al.76 consider that clinical behavior of pediatric cholesteatoma
is so different in adults that it should be considered a different
disease.
Quaranta et al.77 tried to check whether the clinical
behavior of cholesteatomas in children would depend on
histomorphological characteristics of the perimatrix. They
compared the number of plasmocytes, lymphocytes,
macrophages, granulocytes and giant cell in the perimatrix of
samples taken from 30 patients aged less than 16 years with
those of 30 adults, used as controls. The results suggested that
in children the number of inflammatory mononuclear elements
of the perimatrix would be higher than in adults, with evident
activity of the collagenase enzyme. Based on this behavior, the
authors suggested that the perimatrix characteristics could place
an important role in the pathogenesis of cholesteatoma, and it
could be one of the factors that justified the clinical differences
between children and adults.
Bujia et al.73 analyzed the expression of MIB1
(monoclonal antibody marker of cell proliferation) in 20
cholesteatoma in children, whose controls were 15
cholesteatomas in adults and skin of the external auditory
canal. Immunohistochemical analysis showed normal indexes
of epidermis in the canal and increased levels in both
categories of cholesteatomas. However, the number of cells
in proliferation was significantly higher in the pediatric group
(p<0.01). When they compared infected cholesteatomas
with non-infected ones, we did not find any significant
difference, suggesting that the index of proliferation could
be independent from external factors.
Conversely, Edelstein78 stated that pediatric
cholesteatoma would be less expansive, which would take to
smaller incidence of complications and that adults would be
more susceptible to facial palsy, intracranial infection, labyrinthic
fistula and ossicle erosion. Disagreeing with this author, Darrouzet
et al.79 suggested that fewer complications in the pediatric group
would be caused by the fact that in this group the duration of
the disease is on average below what is found in adults.
However, the consensus among most of the authors is
that recurrent cholesteatoma, that is, development of a new
cholesteatoma after surgical treatment, and residual
cholesteatoma, which is originated from the growth of non-
removed parts of the cholesteatoma during the surgery 80, are
more common in the pediatric group and the average recurrence
rate is 30%, compared to 3% to 15% in adults 78,81. Prescott58
followed 81 children with CCOM in a cohort of 10 years and
found a percentage of cholesteatoma recurrence of 12%. Lino
et al.82 conducted a study in 83 children with CCOM and found
25% of recurrence, whereas residual cholesteatoma was
diagnosed in 42%. These authors suggested that recurrence of
cholesteatoma could be intimately related with auditory tube
dysfunction and that high rate of proliferation of matrix could
be responsible for residual cholesteatomas.
Ruah et al.72 suggested that persistence of
mesenchymal and major inflammatory reaction observed
in the flaccid pars and in the posterior-superior quadrant of
pars tense of tympanic membrane, as well as collagen and
elastic affections observed in purulent and serous otitis
media, can represent a pathological justification for the
typical development of cholesteatoma in children.
Management of Cholesteatoma
Treatment of CCOM is essentially surgical. The
primary objective is complete eradication of the disease,
providing to the patient a dry and complication-free ear.
The secondary objective, although not less important, is to
preserve or improve the tympano-ossicle system function,
whenever possible 83.
The first one is reached through meticulous removal
of the whole cholesteatoma (including the matrix and
perimatrix in the wall up technique) and other compromised
tissues. To that end, a variety of surgical techniques has been
used, but they are summed up into two basic ones, depending
on the removal or sparing of the posterior wall of the external
auditory canal: wall up or wall down mastoidectomy. Regardless
of the technique, the secret to surgical success is complete
eradication of the disease. The selection of the procedures is
based on type, grade and extension of cholesteatoma; in the
preoperative auditory assessment, including presence of
associated complications, contralateral ear status, together with
auditory tube function and level of mastoid pneumatization.
This choice will also depend on general patients’ conditions,
age, origin and profession 1.
The wall down technique can be safer concerning
eradication and prevention of recurrence, but it does not
allow preservation of the anatomy and sometimes the level
of preoperative hearing 84. We should bear in mind that the
approach creates a cavity that will require careful and long
medical follow up in addition to demanding general care for
the whole life of the patient, characterizing a limiting factor
for some sports such as swimming and scuba diving 85.
However, the wall down technique, when compared to the
wall up technique, presents less incidence of residual
cholesteatoma 86, regardless of the fact that the rate varies a
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lot depending on the author 87-92. In all studies, it is always
higher among children (Charts 2 and 3, below, adapted from
Darrouzet et al.79).
Since the first report of mastoidectomy technique, in
1649, by Riolanus, up to today, the surgery has been through
a gradual evolution, supported by field studies and
technological development. However, surgical management
of cholesteatomas in children is still the key controversy
among otologists 93-95. To define the best therapeutic strategy,
especially in this special group of patients, it is necessary to
consider many factors such as total eradication of the disease
and preservation of auditory function; for the final decision,
all factors should be properly considered and analyzed. The
key issue is that up to present, no histological or biochemical
differences have been found among cholesteatomas in
different age ranges that could confirm or not the
aggressiveness of CCOM in pediatric cases, a fact that would
justify the use of less conservative surgical techniques.
The next steps
One of the first steps in the advance of understanding
and treating cholesteatomas is the interaction between clinical,
histological and experimental studies.
The connection between these three lines of research
will be essential to understand CCOM.
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